首页 > 按专业查询名词 > 查询PubMed相关文献
名词信息
Pubmed相关的文献
type 2 diabetes with myopathy相关文献:
Myopathy secondary to empagliflozin therapy in type 2 diabetes.
PMID:
Enhancing diabetic muscle repair through W-GA nanodots: a nanomedicinal approach to ameliorate myopathy in type 2 diabetes.
PMID:
[Mitochondrial myopathy, deafness and type 2 diabetes mellitus with tRNALeu(UUR) point mutation in mitochondrial DNA].
PMID:
Human skeletal muscle CD90+ fibro-adipogenic progenitors are associated with muscle degeneration in type 2 diabetic patients.
Farup J, Just J, de Paoli F, Lin L, Jensen JB, Billeskov T, Roman IS, Cömert C, Møller AB, Madaro L, Groppa E, Fred RG, Kampmann U, Gormsen LC, Pedersen SB, Bross P, Stevnsner T, Eldrup N, Pers TH, Rossi FMV, Puri PL, Jessen N.
Cell Metab. 2021 Nov 2;33(11):2201-2214.e11. doi: 10.1016/j.cmet.2021.10.001. Epub 2021 Oct 21.
PMID:34678202
Skeletal muscle mitochondrial remodeling in exercise and diseases.
Gan Z, Fu T, Kelly DP, Vega RB.
Cell Res. 2018 Oct;28(10):969-980. doi: 10.1038/s41422-018-0078-7. Epub 2018 Aug 14.
PMID:30108290
Skeletal muscle inflammation and insulin resistance in obesity.
Wu H, Ballantyne CM.
J Clin Invest. 2017 Jan 3;127(1):43-54. doi: 10.1172/JCI88880. Epub 2017 Jan 3.
PMID:28045398
Targeting the myostatin signaling pathway to treat muscle loss and metabolic dysfunction.
Lee SJ.
J Clin Invest. 2021 May 3;131(9):e148372. doi: 10.1172/JCI148372.
PMID:33938454
Type 2 Diabetes Induces Mitochondrial Dysfunction in Zebrafish Skeletal Muscle Leading to Diabetic Myopathy via the miR-139-5p/NAMPT Pathway.
Chen Z, Zhou Z, Deng Q, Zou Y, Wang B, Huang S, Tian J, Zheng L, Peng X, Tang C.
Int J Mol Sci. 2025 Jan 17;26(2):752. doi: 10.3390/ijms26020752.
PMID:39859466
Skeletal muscle disorders as risk factors for type 2 diabetes.
Tammineni ER, Manno C, Oza G, Figueroa L.
Mol Cell Endocrinol. 2025 Apr 1;599:112466. doi: 10.1016/j.mce.2025.112466. Epub 2025 Jan 21.
PMID:39848431
Type 2 diabetes mellitus related sarcopenia: a type of muscle loss distinct from sarcopenia and disuse muscle atrophy.
Liu Z, Guo Y, Zheng C.
Front Endocrinol (Lausanne). 2024 May 24;15:1375610. doi: 10.3389/fendo.2024.1375610. eCollection 2024.
PMID:38854688
Myosteatosis and Type 2 Diabetes Mellitus.
de Oliveira LB, de Oliveira E Silva V, Jucá ÍCL, Dos Santos Torres JVG, Dos Santos Torres MR, Moura F, Bandeira F.
Acta Medica (Hradec Kralove). 2025;68(2):37-44. doi: 10.14712/18059694.2025.17.
PMID:41064888
Rehabilitation of Individuals With Diabetes Mellitus: Focus on Diabetic Myopathy.
Bassi-Dibai D, Santos-de-Araújo AD, Dibai-Filho AV, de Azevedo LFS, Goulart CDL, Luz GCP, Burke PR, Garcia-Araújo AS, Borghi-Silva A.
Front Endocrinol (Lausanne). 2022 Apr 14;13:869921. doi: 10.3389/fendo.2022.869921. eCollection 2022.
PMID:35498435
The impact of type 2 diabetes on the development of tendinopathy.
Cannata F, Vadalà G, Ambrosio L, Napoli N, Papalia R, Denaro V, Pozzilli P.
Diabetes Metab Res Rev. 2021 Sep;37(6):e3417. doi: 10.1002/dmrr.3417. Epub 2020 Nov 6.
PMID:33156563
© Copyright 2021 鸿泰茂源  版权所有All Rights Reserved京ICP备11040441号-3